LncRNA H19 is involved in myocardial ischemic preconditioning via increasing the stability of nucleolin protein.


Journal

Journal of cellular physiology
ISSN: 1097-4652
Titre abrégé: J Cell Physiol
Pays: United States
ID NLM: 0050222

Informations de publication

Date de publication:
09 2020
Historique:
received: 03 07 2019
accepted: 09 01 2020
pubmed: 25 1 2020
medline: 12 3 2021
entrez: 25 1 2020
Statut: ppublish

Résumé

Myocardial ischemic preconditioning (IP) is defined as a brief period of myocardial ischemia/reperfusion (I/R) that significantly reduces injury during the subsequent exposure to long-term I/R. However, the underlying mechanisms of myocardial IP are yet to be elucidated. This study investigated the expression and roles of long noncoding RNA (lncRNA) H19 in myocardial IP in vitro and in vivo. LncRNA H19 expression levels were analyzed by quantitative reverse-transcription polymerase chain reaction, cell viability was determined by the Cell Counting Kit-8 assay, apoptosis was evaluated based on the caspase 3 activity, and RNA immunoprecipitation was performed to examine the interaction between lncRNA H19 and nucleolin. The results of this study showed that lncRNA H19 expression was significantly upregulated in mouse hearts subjected to myocardial IP, in rat H9C2 cells exposed to H

Identifiants

pubmed: 31975412
doi: 10.1002/jcp.29524
doi:

Substances chimiques

H19 long non-coding RNA 0
Phosphoproteins 0
RNA, Long Noncoding 0
RNA-Binding Proteins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

5985-5994

Informations de copyright

© 2020 Wiley Periodicals, Inc.

Références

Bartolomei, M. S., Zemel, S., & Tilghman, S. M. (1991). Parental imprinting of the mouse H19 gene. Nature, 351(6322), 153-155. https://doi.org/10.1038/351153a0
Bose, S., Tholanikunnel, T. E., Reuben, A., Tholanikunnel, B. G., & Spicer, E. K. (2016). Regulation of nucleolin expression by miR-194, miR-206, and HuR. Molecular and Cellular Biochemistry, 417(1-2), 141-153. https://doi.org/10.1007/s11010-016-2721-2
Cai, B., Ma, W., Bi, C., Yang, F., Zhang, L., Han, Z., … Lu, Y. (2016). Long noncoding RNA H19 mediates melatonin inhibition of premature senescence of c-kit(+) cardiac progenitor cells by promoting miR-675. Journal of Pineal Research, 61(1), 82-95. https://doi.org/10.1111/jpi.12331
Cai, B., Ma, W., Ding, F., Zhang, L., Huang, Q., Wang, X., … Yang, B. (2018). The long noncoding RNA CAREL controls cardiac regeneration. Journal of the American College of Cardiology, 72(5), 534-550. https://doi.org/10.1016/j.jacc.2018.04.085
Dykes, I. M., & Emanueli, C. (2017). Transcriptional and post-transcriptional gene regulation by long non-coding RNA. Genomics, Proteomics & Bioinformatics, 15(3), 177-186. https://doi.org/10.1016/j.gpb.2016.12.005
Fan, W., Peng, Y., Liang, Z., Yang, Y., & Zhang, J. (2019). A negative feedback loop of H19/miR-675/EGR1 is involved in diabetic nephropathy by downregulating the expression of the vitamin D receptor. Journal of Cellular Physiology, 234, 17505-17513. https://doi.org/10.1002/jcp.28373
Geng, H., Bu, H. F., Liu, F., Wu, L., Pfeifer, K., Chou, P. M., … Tan, X. D. (2018). In inflamed intestinal tissues and epithelial cells, interleukin 22 signaling increases expression of H19 long noncoding RNA, which promotes mucosal regeneration. Gastroenterology, 155(1), 144-155.
Gong, L. C., Xu, H. M., Guo, G. L., Zhang, T., Shi, J. W., & Chang, C. (2017). Long non-coding RNA H19 protects H9c2 cells against hypoxia-induced injury by targeting microRNA-139. Cellular Physiology and Biochemistry, 44(3), 857-869. https://doi.org/10.1159/000485354
He, D., Zeng, H., Chen, J., Xiao, L., Zhao, Y., & Liu, N. (2019). H19 regulates trophoblastic spheroid adhesion by competitively binding to let-7. Reproduction, 157, 423-430. https://doi.org/10.1530/rep-18-0339
Heusch, G. (2015). Molecular basis of cardioprotection: Signal transduction in ischemic pre-, post-, and remote conditioning. Circulation Research, 116(4), 674-699. https://doi.org/10.1161/circresaha.116.305348
Hu, Q., Yin, J., Zeng, A., Jin, X., Zhang, Z., Yan, W., … You, Y. (2018). H19 functions as a competing endogenous RNA to regulate EMT by sponging miR-130a-3p in glioma. Cellular Physiology and Biochemistry, 50(1), 233-245.
Huang, Z. W., Tian, L. H., Yang, B., & Guo, R. M. (2017). Long noncoding RNA H19 acts as a competing endogenous RNA to mediate CTGF expression by sponging miR-455 in cardiac fibrosis. DNA and Cell Biology, 36(9), 759-766. https://doi.org/10.1089/dna.2017.3799
Jia, W., Yao, Z., Zhao, J., Guan, Q., & Gao, L. (2017). New perspectives of physiological and pathological functions of nucleolin (NCL). Life Sciences, 186, 1-10. https://doi.org/10.1016/j.lfs.2017.07.025
Jiang, B., Liang, P., Wang, K., Lv, C., Sun, L., Tong, Z., … Xiao, X. (2014). Nucleolin involved in myocardial ischaemic preconditioning via post-transcriptional control of HSPA1A expression. Cardiovascular Research, 102(1), 56-67. https://doi.org/10.1093/cvr/cvu006
Jiang, B., Wang, K., Liang, P., Xiao, W., Wang, H., & Xiao, X. (2009). ATP-binding domain of heat shock protein 70 is essential for its effects on the inhibition of the release of the second mitochondria-derived activator of caspase and apoptosis in C2C12 cells. FEBS Journal, 276(9), 2615-2624. https://doi.org/10.1111/j.1742-4658.2009.06989.x
Jiang, B., Zhang, B., Liang, P., Chen, G., Zhou, B., Lv, C., … Xiao, X. (2013). Nucleolin protects the heart from ischaemia-reperfusion injury by up-regulating heat shock protein 32. Cardiovascular Research, 99(1), 92-101. https://doi.org/10.1093/cvr/cvt085
Jiang, B., Zhang, B., Liang, P., Song, J., Deng, H., Tu, Z., … Xiao, X. (2010). Nucleolin/C23 mediates the antiapoptotic effect of heat shock protein 70 during oxidative stress. FEBS Journal, 277(3), 642-652. https://doi.org/10.1111/j.1742-4658.2009.07510.x
Li, D. Y., Busch, A., Jin, H., Chernogubova, E., Pelisek, J., Karlsson, J., Sennblad, B., … Maegdefessel, L. (2018). H19 induces abdominal aortic aneurysm development and progression. Circulation, 138(15), 1551-1568.
Li, X., Wang, H., Yao, B., Xu, W., Chen, J., & Zhou, X. (2016). lncRNA H19/miR-675 axis regulates cardiomyocyte apoptosis by targeting VDAC1 in diabetic cardiomyopathy. Scientific Reports, 6, 36340. https://doi.org/10.1038/srep36340
Liu, G. S., Thornton, J., Van Winkle, D. M., Stanley, A. W., Olsson, R. A., & Downey, J. M. (1991). Protection against infarction afforded by preconditioning is mediated by A1 adenosine receptors in rabbit heart. Circulation, 84(1), 350-356.
Liu, L., An, X., Li, Z., Song, Y., Li, L., Zuo, S., … Wang, J. (2016). The H19 long noncoding RNA is a novel negative regulator of cardiomyocyte hypertrophy. Cardiovascular Research, 111(1), 56-65. https://doi.org/10.1093/cvr/cvw078
Liu, Y., Gao, W. D., O'Rourke, B., & Marban, E. (1996). Synergistic modulation of ATP-sensitive K + currents by protein kinase C and adenosine. Implications for ischemic preconditioning. Circulation Research, 78(3), 443-454.
Liu, Y., Ytrehus, K., & Downey, J. M. (1994). Evidence that translocation of protein kinase C is a key event during ischemic preconditioning of rabbit myocardium. Journal of Molecular and Cellular Cardiology, 26(5), 661-668. https://doi.org/10.1006/jmcc.1994.1078
Lu, M., Tian, H., Cao, Y. X., He, X., Chen, L., Song, X., … Sun, F. (2015). Downregulation of miR-320a/383-sponge-like long non-coding RNA NLC1-C (narcolepsy candidate-region 1 genes) is associated with male infertility and promotes testicular embryonal carcinoma cell proliferation. Cell Death & Disease, 6, e1960. https://doi.org/10.1038/cddis.2015.267
Luo, H., Wang, J., Liu, D., Zang, S., Ma, N., Zhao, L., … Qiao, C. (2019). The lncRNA H19/miR-675 axis regulates myocardial ischemic and reperfusion injury by targeting PPARalpha. Molecular Immunology, 105, 46-54. https://doi.org/10.1016/j.molimm.2018.11.011
Lyu, Q. L., Jiang, B. M., Zhou, B., Sun, L., Tong, Z. Y., Li, Y. B., … Xiao, X. Z. (2018). MicroRNA Profiling of Transgenic Mice with Myocardial Overexpression of Nucleolin. Chinese Medical Journal (England), 131(3), 339-346. https://doi.org/10.4103/0366-6999.223853
Muller, V., Ferrer, L. O., Steinbach, B., Pantel, K., & Schwarzenbach, H. (2019). Interplay of lncRNA H19/miR-675 and lncRNA NEAT1/miR-204 in breast cancer. Molecular Oncology, 13, 1137-1149. https://doi.org/10.1002/1878-0261.12472
Murry, C. E., Jennings, R. B., & Reimer, K. A. (1986). Preconditioning with ischemia: A delay of lethal cell injury in ischemic myocardium. Circulation, 74(5), 1124-1136.
Park, K.-S., Mitra, A., Rahat, B., Kim, K., & Pfeifer, K. (2017). Loss of imprinting mutations define both distinct and overlapping roles for misexpression of IGF2 and of H19 lncRNA. Nucleic Acids Research, 45(22), 12766-12779.
Reister, S., Mahotka, C., van den Hofel, N., & Grinstein, E. (2019). Nucleolin promotes Wnt signaling in human hematopoietic stem/progenitor cells. Leukemia, 33, 1052-1054. https://doi.org/10.1038/s41375-019-0401-4
Sallam, T., Sandhu, J., & Tontonoz, P. (2018). Long noncoding RNA discovery in cardiovascular disease: Decoding form to function. Circulation Research, 122(1), 155-166. https://doi.org/10.1161/circresaha.117.311802
Salloum, F. N., Yin, C., & Kukreja, R. C. (2010). Role of microRNAs in cardiac preconditioning. Journal of Cardiovascular Pharmacology, 56(6), 581-588. https://doi.org/10.1097/FJC.0b013e3181f581ba
Shin, S.-H., Lee, G. Y., Lee, M., Kang, J., Shin, H.-W., Chun, Y.-S., & Park, J.-W. (2018). Aberrant expression of CITED2 promotes prostate cancer metastasis by activating the nucleolin-AKT pathway. Nature Communications, 19(1), 4113.
Sun, H., Tong, Z., Fang, Y., Jiang, B., Liang, P., Tang, Y., … Xiao, X. (2018). Nucleolin protects against doxorubicin-induced cardiotoxicity via upregulating microRNA-21. Journal of Cellular Physiology, 233(12), 9516-9525. https://doi.org/10.1002/jcp.26854
Thum, T., & Condorelli, G. (2015). Long noncoding RNAs and microRNAs in cardiovascular pathophysiology. Circulation Research, 116(4), 751-762. https://doi.org/10.1161/circresaha.116.303549
Van Long, F. N., Lardy-Cleaud, A., Bray, S., Chabaud, S., Dubois, T., Diot, A., Jordan, L. B., … Christophe, J. (2018). Druggable identifies breast tumours associated with poor prognosis that exhibit different biological processes. Cancers (Basel), 10(10), 390.
Wang, R., Zhou, S., Wu, P., Li, M., Ding, X., Sun, L., … Fei, G. (2018). Identifying Involvement of H19-miR-675-3p-IGF1R and H19-miR-200a-PDCD4 in treating pulmonary hypertension with melatonin. Molecular Therapy. Nucleic Acids, 13, 44-54. https://doi.org/10.1016/j.omtn.2018.08.015
Wang, S., Chen, X., Wang, M., Yao, D., Chen, T., Yan, Q., & Lu, W. (2018). Long non-coding RNA CYP4B1-PS1-001 inhibits proliferation and fibrosis in diabetic nephropathy by interacting with nucleolin. Cellular Physiology and Biochemistry, 49(6), 2174-2187. https://doi.org/10.1159/000493821
Wu, Z. R., Yan, L., Liu, Y. T., Cao, L., Guo, Y. H., Zhang, Y., … Wu, Z. B. (2018). Inhibition of mTORC1 by lncRNA H19 via disrupting 4E-BP1/Raptor interaction in pituitary tumours. Nature Communications, 9(1), 4624. https://doi.org/10.1038/s41467-018-06853-3
Zhang, X., Cheng, L., Xu, L., Zhang, Y., Yang, Y., Fu, Q., … Li, H. (2018). The lncRNA, H19 mediates the protective effect of hypoxia postconditioning against hypoxia-reoxygenation injury to senescent cardiomyocytes by targeting microRNA-29b-3p. Shock, 52, 249-256. https://doi.org/10.1097/shk.0000000000001213
Zhang, Y., Sun, L., Xuan, L., Pan, Z., Hu, X., Liu, H., … Yang, B. (2018). Long non-coding RNA CCRR controls cardiac conduction via regulating intercellular coupling. Nature Communications, 9(1), 4176. https://doi.org/10.1038/s41467-018-06637-9
Zhang, Y., Zhang, M., Xu, W., Chen, J., & Zhou, X. (2017). The long non-coding RNA H19 promotes cardiomyocyte apoptosis in dilated cardiomyopathy. Oncotarget, 8(17), 28588-28594. https://doi.org/10.18632/oncotarget.15544
Zhou, M., Zou, Y. G., Xue, Y. Z., Wang, X. H., Gao, H., Dong, H. W., & Zhang, Q. (2018). Long non-coding RNA H19 protects acute myocardial infarction through activating autophagy in mice. European Review for Medical and Pharmacological Sciences, 22(17), 5647-5651. https://doi.org/10.26355/eurrev_201809_15831

Auteurs

Cheng Chen (C)

Department of Pathophysiology, Sepsis Translational Medicine Key Laboratory of Hunan Province, Xiangya School of Medicine, Central South University, Changsha, Hunan, China.

Meidong Liu (M)

Department of Pathophysiology, Sepsis Translational Medicine Key Laboratory of Hunan Province, Xiangya School of Medicine, Central South University, Changsha, Hunan, China.

Yuting Tang (Y)

Department of Pathophysiology, Sepsis Translational Medicine Key Laboratory of Hunan Province, Xiangya School of Medicine, Central South University, Changsha, Hunan, China.

Hui Sun (H)

Department of Pathophysiology, Sepsis Translational Medicine Key Laboratory of Hunan Province, Xiangya School of Medicine, Central South University, Changsha, Hunan, China.

Xiaofang Lin (X)

Department of Pathophysiology, Sepsis Translational Medicine Key Laboratory of Hunan Province, Xiangya School of Medicine, Central South University, Changsha, Hunan, China.

Pengfei Liang (P)

Department of Burns and Plastic Surgery, Xiangya Hospital, Central South University, Changsha, Hunan, China.

Bimei Jiang (B)

Department of Pathophysiology, Sepsis Translational Medicine Key Laboratory of Hunan Province, Xiangya School of Medicine, Central South University, Changsha, Hunan, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH